Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK. PLoS ONE. 2021;16(7): e0252048. Article CAS PubMed PubMed Central Google Scholar Chen K, Si Y, Ou J, Guan JS, Kim S, Ernst P, et al. ...
[8] Byers P.H., Osteogenesis imperfecta: perspectives and opportunities, Curr. Opin. Pediatr., 2000, 12, 603–609 http://dx.doi.org/10.1097/00008480-200012000-0001610.1097/00008480-200012000-00016Search in Google Scholar PubMed [9] Mc Allion S.J., Paterson C.R., Causes of death in ost...